Brad Amos, MD, PhD, FAAD
Board-Certified Dermatologist
4.7 /5
208 reviews
google
5.0/5
Forefront Dermatology
Dr Amos is attentive and knowledgeable
google
5.0/5
Forefront Dermatology
I have been a patient of Dr. Amos for many years, and have always been very pleased with the treatment I’ve received. Dr. Amos is extremely knowledgeable and thorough in his examinations and treatment recommendations. He takes the time to listen to concerns, and has a caring and professional demeanor. He’s an excellent Dermatologist. The staff is also very friendly and helpful.
google
5.0/5
Forefront Dermatology
Very quick diagnosis and remedy.
google
5.0/5
Forefront Dermatology
Very professional and knowledgeable
google
5.0/5
Forefront Dermatology
Professional and courteous. Explained everything very well. Would recommend
google
5.0/5
Forefront Dermatology
Great service, quick, and very personal.
google
5.0/5
Forefront Dermatology
Office is well organized, patients are treated with respect and if have any questions staff is willing to accommodate! J. P.
google
5.0/5
Forefront Dermatology
Dr Amos is always thorough and engaging!
google
5.0/5
Forefront Dermatology
Staff is efficient, professional and friendly; genuinely cared about providing me with quality exam during my appointment. Dr. Amos, is personable and gave a thorough exam explaining the skin concerns I had. Highly recommend !
google
5.0/5
Forefront Dermatology
It was a very positive experience. Everyone was very pleasant, kind and helpful.
Education

Undergraduate Degree:

BS, University of Pittsburgh – Pittsburgh, PA

Doctorate Degree:

PhD, University of Texas – Houston, TX

Medical School:

MD, Baylor College of Medicine – Houston, TX

Dermatology Residency:

University of Pittsburgh – Pittsburgh, PA

Certificates
American Board of Dermatology
Publications
  • Barnes DW, Mousetis L, Amos B, and Silnutzer J Glass Bead Chromatography of Cell Attachment and Spreading Promoting Factors in Human Serum. Anal. Biochem. 127: 196-204, 1984.
  • Barnes DW, Reing JE, and Amos B. Heparin Binding Properties Of Human Serum Spreading Factor. J. Biol. Chem. 260: 9117-9122, 1985.
  • Lotan R, Lotan, D, and Amos B. Sialyltransferase in Two Melanoma Cell Lines That are Growth Inhibited by Retinoic Acid Results in Increased Sialylation of Different Cell Surface Glycoproteins. Exp. Cell Res. I 77: 284-294, 1988.
  • Amos, B. Clifford J. and Lotan R. Modulation of Melanoma Growth and Differentiation by Retinoids. Shroot 8. ed.
    “Pharmacology of Retino1ds m the Skin” S Karger, Basel· vol3: 29-36, 1989.
  • Sacks PG, Oke V, Amos B, Vasey T, and Lotan R. Modulation of Growth, Differentiation, and Glycoprotein Synthesis by P All Trans Retinoic Acid in a Multicellular Tumor Spheroid Model for Squamous Carcinoma of the Head and Neck.  Int. J Cancer 99: 926-933, 1989.
  • Amos B, Deutsch V, and Lotan R. Modulation by All Trans Retinoic Acid ofGlycosylation in Murine Melanoma Cells: Enhancement of Fucosyl and Galactosyltransferase Activities. CancerBiochem. B1ophys. 11: 31-43, 1990.
  • Amos B, Lotan D, and Lotan R. Increased Fucosylation of High Molecular Weight Glycoproteins Accompanies Retinoic Acid Differentiation ofF-9 Embryonal Carcinoma Cells. Int. J Cancer 46: 86-94, 1990.
  • Amos B and Lotan R. Modulation of Lysosomal Associated Membrane Glycoproteins (LAMPs 1 and 2) in Embryonal Carcinoma Cells Induced to Differentiate by Retinoic Acid. J. Biol. Chem. 265: 19192-19198, 1990.
  • Amos B and Lotan R. Retinoid Sensitive Cells and Cell Lines. In L. Packer (ed) Methods in Enzymology: Retinoids. Academic Press, Orlando. 190: 217-225
    Lotan R, Amos B, Watanabe H, and Raz A. Suppression ofMelanoma Cell Motility Factor Receptor Expression by Retinoic Acid. Cancer Res. 52: 4878-4884, 1992.
  • Heffernan M, Lotan R. Palcic M, Amos B, and Dennis JW. Branching of 13 l-6N-Acetylglucosamine-Transferase and Polylactosamine Expression in Mouse F-9 Teratocarcinorna Cells: Modulation During Retinoic Acid Induced Differentiation. J. Biol. Chem. 268: 1242-1251, 1993.
  • Sacks PG. Amos B, and Lotan R. Enhancement of Glycosylation of Cellular G\yconjugates in the Squamous Cell LineMDA886Ln by 13 All Trans Retinoic Acid. GlycoconjugateJ. 13: 791-796, 1996. Amos B, Deng JS, and Suarez S. Bullous Pemphlgoid in Infancy Case Report and Literature Review. Ped. Dermatol. 15: I 08-111, 1998.
  • Lu Y, Amos B, Cruise E, Lotan D, and Lotan R. A Parallel Association Between Differentiation and Induction of Galectin-1, And lnhibition of Galectin-3 by Retinoic Acid in Mouse Embryonal Carcinoma F9 Cells. Biol. Chem. 11: 1323-1331, 1998.
  • Chew J, Gin l, Rau KA, Amos B, and Bridenstine JB. Treatment of Upper Lip Wrinkles: A Comparison of950 musec Dwell Time Carbon Dioxide Laser with Unoccluded Baker’s Phenol Chemical Peel. Dermato/. Surg. 25: 262-266, 1999.
  • Gin I, Chew J, Rau KA, Amos DB, and Bridenstine JB. Treatment Of Upper Lip Wrinkles: A Comparison of950 musec Dwell Time Carbon Dioxide Laser to Manual Tumescent Dermabrasion. Dermatol. Surg. 25: 468-474, 1999.
  • Rau KA, Chew J, Gin I, Amos DB, and BridenstineJB. Treatment of Upper Lip Wrinkles: A Comparison of the Sharplan Silktouch Carbon Dioxide Laser with Ellman Radiosurgery.
    Am.Jo/CosmeticSurg. 17: 9-14,2000.

*Age Restriction


For patients scheduling who are under 18 years of age (19 in Alabama) please make sure you have permission from your parent or legal guardian to schedule this appointment.  Your parent or legal guardian must accompany you on your initial visit and on certain subsequent visits to provide appropriate informed consent.